Operating Income (Loss) in USD of Cogent Biosciences, Inc. from Q1 2017 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Cogent Biosciences, Inc. quarterly/annual Operating Income (Loss) history and change rate from Q1 2017 to Q3 2025.
  • Cogent Biosciences, Inc. Operating Income (Loss) for the quarter ending 30 Sep 2025 was -$83.4M, a 10.5% decline year-over-year.
  • Cogent Biosciences, Inc. Operating Income (Loss) for the twelve months ending 30 Sep 2025 was -$308M, a 18.1% decline year-over-year.
  • Cogent Biosciences, Inc. annual Operating Income (Loss) for 2024 was -$276M, a 32.6% decline from 2023.
  • Cogent Biosciences, Inc. annual Operating Income (Loss) for 2023 was -$208M, a 40.8% decline from 2022.
  • Cogent Biosciences, Inc. annual Operating Income (Loss) for 2022 was -$148M, a 95.7% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Change (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Change (%)

Cogent Biosciences, Inc. Quarterly Operating Income (Loss) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$308M -$83.4M -$7.94M -10.5% 01 Jul 2025 30 Sep 2025 10-Q 07 Nov 2025
Q2 2025 -$300M -$75.6M -$11.2M -17.4% 01 Apr 2025 30 Jun 2025 10-Q 05 Aug 2025
Q1 2025 -$288M -$74.9M -$12.5M -20.1% 01 Jan 2025 31 Mar 2025 10-Q 06 May 2025
Q4 2024 -$276M -$73.7M -$15.5M -26.6% 01 Oct 2024 31 Dec 2024 10-K 25 Feb 2025
Q3 2024 -$260M -$75.4M -$15.8M -26.6% 01 Jul 2024 30 Sep 2024 10-Q 07 Nov 2025
Q2 2024 -$245M -$64.4M -$17.3M -36.7% 01 Apr 2024 30 Jun 2024 10-Q 05 Aug 2025
Q1 2024 -$227M -$62.4M -$19.2M -44.3% 01 Jan 2024 31 Mar 2024 10-Q 06 May 2025
Q4 2023 -$208M -$58.2M -$14.5M -33.1% 01 Oct 2023 31 Dec 2023 10-K 25 Feb 2025
Q3 2023 -$194M -$59.6M -$22.8M -61.8% 01 Jul 2023 30 Sep 2023 10-Q 12 Nov 2024
Q2 2023 -$171M -$47.1M -$11.2M -31.3% 01 Apr 2023 30 Jun 2023 10-Q 06 Aug 2024
Q1 2023 -$160M -$43.2M -$11.8M -37.6% 01 Jan 2023 31 Mar 2023 10-Q 07 May 2024
Q4 2022 -$148M -$43.7M -$18.1M -70.6% 01 Oct 2022 31 Dec 2022 10-K 25 Feb 2025
Q3 2022 -$130M -$36.8M -$17M -85.8% 01 Jul 2022 30 Sep 2022 10-Q 07 Nov 2023
Q2 2022 -$113M -$35.9M -$18.6M -107% 01 Apr 2022 30 Jun 2022 10-Q 08 Aug 2023
Q1 2022 -$94.2M -$31.4M -$18.6M -145% 01 Jan 2022 31 Mar 2022 10-Q 09 May 2023
Q4 2021 -$75.6M -$25.6M -$14.2M -124% 01 Oct 2021 31 Dec 2021 10-K 26 Feb 2024
Q3 2021 -$61.4M -$19.8M +$37.4M +65.4% 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022
Q2 2021 -$98.7M -$17.3M -$9.89M -134% 01 Apr 2021 30 Jun 2021 10-Q 09 Aug 2022
Q1 2021 -$88.9M -$12.8M -$6.66M -108% 01 Jan 2021 31 Mar 2021 10-Q 10 May 2022
Q4 2020 -$82.2M -$11.5M -$13.7M -611% 01 Oct 2020 31 Dec 2020 10-K 15 Mar 2022
Q3 2020 -$68.5M -$57.2M -$45.2M -375% 01 Jul 2020 30 Sep 2020 10-Q 10 Nov 2021
Q2 2020 -$23.3M -$7.4M +$3.14M +29.8% 01 Apr 2020 30 Jun 2020 10-Q 16 Aug 2021
Q1 2020 -$26.5M -$6.14M +$5.7M +48.1% 01 Jan 2020 31 Mar 2020 10-Q 12 May 2021
Q4 2019 -$32.2M $2.24M +$11.2M 01 Oct 2019 31 Dec 2019 10-K 26 Mar 2020
Q3 2019 -$43.4M -$12M -$1.46M -13.8% 01 Jul 2019 30 Sep 2019 10-Q 09 Nov 2020
Q2 2019 -$42M -$10.5M -$1.1M -11.7% 01 Apr 2019 30 Jun 2019 10-Q 11 Aug 2020
Q1 2019 -$40.9M -$11.8M -$4.86M -69.5% 01 Jan 2019 31 Mar 2019 10-Q 11 May 2020
Q4 2018 -$36M -$9M -$2.12M -30.9% 01 Oct 2018 31 Dec 2018 10-K 26 Mar 2020
Q3 2018 -$33.9M -$10.6M -$3.41M -47.5% 01 Jul 2018 30 Sep 2018 10-K 26 Mar 2020
Q2 2018 -$30.5M -$9.44M -$3.41M -56.5% 01 Apr 2018 30 Jun 2018 10-K 26 Mar 2020
Q1 2018 -$27.1M -$6.99M -$917K -15.1% 01 Jan 2018 31 Mar 2018 10-K 26 Mar 2020
Q4 2017 -$26.2M -$6.88M 01 Oct 2017 31 Dec 2017 10-K 28 Mar 2019
Q3 2017 -$7.17M 01 Jul 2017 30 Sep 2017 10-K 28 Mar 2019
Q2 2017 -$6.03M 01 Apr 2017 30 Jun 2017 10-K 28 Mar 2019
Q1 2017 -$6.07M 01 Jan 2017 31 Mar 2017 10-K 28 Mar 2019

Cogent Biosciences, Inc. Annual Operating Income (Loss) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$276M -$67.8M -32.6% 01 Jan 2024 31 Dec 2024 10-K 25 Feb 2025
2023 -$208M -$60.3M -40.8% 01 Jan 2023 31 Dec 2023 10-K 25 Feb 2025
2022 -$148M -$72.3M -95.7% 01 Jan 2022 31 Dec 2022 10-K 25 Feb 2025
2021 -$75.6M +$6.65M +8.09% 01 Jan 2021 31 Dec 2021 10-K 26 Feb 2024
2020 -$82.2M -$50M -155% 01 Jan 2020 31 Dec 2020 10-K 15 Mar 2022
2019 -$32.2M +$3.83M +10.6% 01 Jan 2019 31 Dec 2019 10-K 16 Mar 2021
2018 -$36M -$9.85M -37.7% 01 Jan 2018 31 Dec 2018 10-K 26 Mar 2020
2017 -$26.2M 01 Jan 2017 31 Dec 2017 10-K 28 Mar 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.